World's Best Scientists 2026 revealed!
Olivier Lantz

Olivier Lantz

D-Index & Metrics

Immunology

D-Index
91
Citations
34666
World Ranking
1027
National Ranking
35

Medicine

D-Index
91
Citations
34915
World Ranking
11645
National Ranking
360

Olivier Lantz publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Olivier Lantz sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 302 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Olivier Lantz D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Olivier Lantz sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 91 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Olivier Lantz is affiliated with the Institute Curie in France and has contributed extensively to research in immunology and microbiology, with significant work also spanning medicine. Their research focuses primarily on immunology, oncology, and molecular biology, supported by numerous publications in these areas.

The scientist's publication record includes important studies such as Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens (2020, Nature Biotechnology), MAIT Cell Development and Functions: the Microbial Connection (2020, Immunity), Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients (2020, Nature Communications), Contribution of resident and circulating precursors to tumor-infiltrating CD8 + T cell populations in lung cancer (2021, Science Immunology), and Mucosal-associated invariant T cells promote inflammation and intestinal dysbiosis leading to metabolic dysfunction during obesity (2020, Nature Communications).

Their frequent co-authors include Ana I. Lalanne, Christophe Le Tourneau, François Legoux, Sebastián Amigorena, and Darragh Duffy. These collaborations reflect ongoing interdisciplinary research efforts linking immunology and oncology.

Olivier Lantz's work is frequently published in venues such as:

  • Nature Communications
  • European Journal of Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • Journal of Clinical Oncology

Their research topics cover a diverse range related to immune cell functions and interactions, including:

  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Cancer Immunotherapy and Biomarkers
  • IL-33, ST2, and ILC Pathways
  • Cervical Cancer and HPV Research

This scientific profile highlights a focus on the immune system's role in cancer and metabolic dysfunctions, reflecting evolving research themes in both immunology and oncology fields. Their body of work includes substantial contributions to understanding tumor immunology, T-cell biology, and immune responses in various disease contexts.

Best Publications

  • Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

    Bernard Escudier;Thierry Dorval;Nathalie Chaput;Fabrice André

  • Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1

    Emmanuel Treiner;Livine Duban;Seiamak Bahram;Mirjana Radosavljevic

  • An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans.

    Olivier Lantz;Albert Bendelac

  • Indirect activation of naïve CD4 + T cells by dendritic cell–derived exosomes

    Clotilde Théry;Livine Duban;Elodie Segura;Philippe Véron

  • Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells

    Pascale André;Caroline Denis;Caroline Soulas;Clarisse Bourbon-Caillet

  • CD1 recognition by mouse NK1+ T lymphocytes

    Albert Bendelac;Albert Bendelac;Olivier Lantz;Mary E. Quimby;Jonathan W. Yewdell

  • Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17–secreting T cells

    Mathilde Dusseaux;Mathilde Dusseaux;Emmanuel Martin;Emmanuel Martin;Nacer Serriari;Isabelle Péguillet

  • Guidelines for the use of flow cytometry and cell sorting in immunological studies

    Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Mübeccel Akdis

  • Antimicrobial activity of mucosal-associated invariant T cells

    Lionel Le Bourhis;Emmanuel Martin;Emmanuel Martin;Isabelle Péguillet;Isabelle Péguillet;Amélie Guihot

  • Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

    Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Andreas Acs

  • Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC

    Benjamin Besse;Mélinda Charrier;Valérie Lapierre;Eric Dansin

  • The Transcription Factor PLZF Directs the Effector Program of the NKT Cell Lineage

    Adam K. Savage;Michael G. Constantinides;Jin Han;Damien Picard

  • Human Mucosal Associated Invariant T Cells Detect Bacterially Infected Cells

    Marielle C. Gold;Marielle C. Gold;Stefania Cerri;Susan Smyk-Pearson;Meghan E. Cansler

  • An invariant T cell receptor α chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted α/β T cell subpopulation in mammals

    Florence Tilloy;Emmanuel Treiner;Se Ho Park;Corinne Garcia

  • Stepwise development of MAIT cells in mouse and human.

    Emmanuel Martin;Emmanuel Treiner;Emmanuel Treiner;Livine Duban;Lucia Guerri

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • CD4 cells can be more efficient at tumor rejection than CD8 cells.

    Ainhoa Perez-Diez;Nathalie T. Joncker;Kyungho Choi;William F. N. Chan

  • Overexpression of Natural Killer T Cells Protects Vα14-Jα281 Transgenic Nonobese Diabetic Mice against Diabetes

    Agnès Lehuen;Olivier Lantz;Lucie Beaudoin;Véronique Laloux

  • Risk of tumorigenicity in mesenchymal stromal cell-based therapies--bridging scientific observations and regulatory viewpoints.

    Lisbeth Barkholt;Lisbeth Barkholt;Egbert Flory;Egbert Flory;Veronika Jekerle;Sophie Lucas-Samuel

  • Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations

    Satoshi Okada;Satoshi Okada;Janet G Markle;Elissa K Deenick;Elissa K Deenick;Federico Mele

Frequent Co-Authors

Jean-Yves Pierga
Jean-Yves Pierga Institute Curie
Jamie Rossjohn
Jamie Rossjohn Monash University
James P. Di Santo
James P. Di Santo Institut Pasteur
Darragh Duffy
Darragh Duffy Institut Pasteur
Lluis Quintana-Murci
Lluis Quintana-Murci Institut Pasteur
Agnès Lehuen
Agnès Lehuen Université Paris Cité
James McCluskey
James McCluskey University of Melbourne
Etienne Patin
Etienne Patin Institut Pasteur
Sebastian Amigorena
Sebastian Amigorena Institute Curie

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens up a variety of career paths, especially when combined with advanced nursing roles. Many professionals pursue online degrees to enhance their expertise while balancing work and personal commitments. For those interested in nursing, exploring the cheapest psych NP programs offers an affordable route to specialize in psychiatric care, which often intersects with immunological disorders.

Advanced practice nurses can further increase their earning potential by understanding factors like the DNP salary by state, which varies considerably based on location and specialization. This knowledge helps plan a career that maximizes both impact and compensation.

For those looking to expand their clinical scope, obtaining an acute care NP certification is a valuable step. It equips nurse practitioners with skills needed to manage complex immunological conditions in critical care settings.

Additionally, accelerated programs provide a fast track to becoming a Family Nurse Practitioner. Checking out the accelerated FNP options online can help students meet their goals efficiently, enabling them to integrate immunology into primary care roles.

Best Scientists Citing Olivier Lantz

Trending Scientists

Recently Published Articles